Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:21:37.522Z.
Calculation as of: 2026-10-06T16:21:37.522Z.
Quote observation: 2026-10-06T16:19:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f1b6469add1457cabf137e6e5cfb012e486d3d2c84b47330ed8a9effb8bf14c7
EARNINGS YIELD
N/A
Market Cap
$64.85M
Earnings Yield
N/A
TTM Avg
34.60%
3Y Avg
34.60%
5Y Avg
34.60%
Market Cap
$63.83M
Earnings Yield
N/A
TTM Avg
2.54%
3Y Avg
2.54%
5Y Avg
2.54%
Market Cap
$67.38M
Earnings Yield
N/A
TTM Avg
4.28%
3Y Avg
4.21%
5Y Avg
1.79%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cingulate Inc. (CING) | $65.80M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $64.96M | N/A | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.85M | N/A | 34.60% | 34.60% | 34.60% |
| RenovoRx, Inc. (RNXT)vs › | $66.30M | N/A | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.83M | N/A | 2.54% | 2.54% | 2.54% |
| Champions Oncology, Inc. (CSBR)vs › | $67.38M | N/A | 4.28% | 4.21% | 1.79% |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $67.84M | N/A | 1.65% | 1.65% | 1.65% |
| InterCure Ltd. (INCR)vs › | $63.02M | N/A | 7.80% | 4.49% | 5.28% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.43M | 130.20% | 107.81% | 107.81% | 107.81% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
